High levels of LDL cholesterol and triglycerides, which are types of blood fats, are major contributors to atherosclerotic cardiovascular disease. Gene-editing technologies offer a potential alternative to lipid-lowering medications. In a new CRISPR experiment, a single infusion of a gene-editing treatment kept triglyceride levels low in monkeys for three years. The findings support the possibility of controlling blood fats with a lasting DNA change, potentially replacing daily doses of medication.
❓ Unknown
CRISPR Infusion Maintains Low Blood Fats in Monkeys for Three Years
Just now
November 14, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
A new CRISPR experiment demonstrated that a single infusion can maintain low triglyceride levels in monkeys for three years, suggesting a potential alternative to traditional lipid-lowering medications. This research could influence future medical treatments for cardiovascular diseases, which are prevalent in Iran. The findings may lead to advancements in healthcare that could benefit the Iranian population.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
Just now •
Davoud Rokhbin Executed for Murder in Kashan Prison
Just now •
Ali Mokhtari Executed for Rape in Shahre Kord
4 min ago •
Abu Dhabi's Risky Strategy in the Strait of Hormuz
7 min ago •
Saedeh Sima Removed from Esteghlal
9 min ago •